Immunogenicity and safety of a combined hepatitis A and B vaccine administered concomitantly with either a measles–mumps–rubella or a diphtheria–tetanus–acellular pertussis-inactivated poliomyelitis vaccine mixed with a Haemophilus influenzae type b conjugate vaccine in infants aged 12–18 months
- 22 December 2004
- Vol. 23 (20), 2602-2606
- https://doi.org/10.1016/j.vaccine.2004.11.062
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven yearsThe Pediatric Infectious Disease Journal, 2000
- Reactogenicity and immunogenicity of a new combined Measles–Mumps–Rubella vaccine: results of a multicentre trialVaccine, 2000
- Safety and Immunogenicity of Haemophilus influenzae‐Tetanus Toxoid Conjugate Vaccine Given Separately or in Combination with a Three‐Component Acellular Pertussis Vaccine Combined with Diphtheria and Tetanus Toxoids and Inactivated Poliovirus Vaccine for the First Four DosesClinical Infectious Diseases, 1999
- Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy childrenThe Pediatric Infectious Disease Journal, 1999
- Development and clinical application of new polyvalent combined paediatric vaccinesVaccine, 1999
- Developing Better Paediatric VaccinesBioDrugs, 1999
- Safety and Immunogenicity of Combined DTPa-IPV Vaccine for Primary and Booster VaccinationScandinavian Journal of Infectious Diseases, 1999
- Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy childrenInfection, 1998
- Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b-tetanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccineThe Pediatric Infectious Disease Journal, 1997
- Comparison of a Three-Component Acellular Pertussis Vaccine With a Whole-Cell Pertussis Vaccine in 15- Through 20-Month-Old InfantsPediatrics, 1994